Of 142 purines, purine nucleosides, and analogues tested for inhibition of growth of Escherichia coli B Hill, 45 were active. Of these, 27 were evaluated for inhibition of other E. coli lines, including those resistant to 6-thioguanine, 2-fluoroadenosine, 2,6-diaminopurine, or 6-mercaptopurine. Most toxic to the parent lines were 2-fluoroadenosine, 2-fluoroadenine, 2-fluoro-5'-deoxyadenosine, adenosine, 6-thioguanosine, 6-thioguanine, 6-mercaptopurine, 6-mercaptopurine ribonucleoside, 2-azaadenine, 2'-deoxyinosine, 6-N-aminoadenine, and inosine. Hypoxanthine was strongly inhibitory only to E. coli B Hill. Evidence regarding the substrate specificity of the three purine phosphoribosyltransferases was obtained by assaying for these enzymes in extracts of the various cell lines and by cross-resistance studies. The line selected for resistance to 6-thioguanine had low guanine phosphoribosyltransferase activity (guanosine monophosphate: pyrophosphate phosphoribosyltransferase, EC 2.4.2.8) and was deficient in activity for xanthine and 6-thioguanine. The lines selected for resistance to 2-fluoroadenosine and 2, 6-diaminopurine were deficient in adenine phosphoribosyltransferase activity (adenosine monophosphate: pyrophosphate phosphoribosyltransferase, EC 2.4.2.7), and that selected for resistance to 6-mercaptopurine had low hypoxanthine phosphoribosyltr .nsferase activity and undetectable activity with 6-mercaptopurine as a substrate. Purine, 6-methylpurine, 2-fluoroadenine, 2,6-diaminopurine, and 2-azaadenine were classified as adenine analogues; 6-mercaptopurine and 8-aza-2, 6-diaminopurine, as hypoxanthine analogues; and 6-thioguanine and 2-amino-6-chloropurine, as analogues of guanine. The inhibition of bacterial growth by hypoxanthine, inosine, 2'-deoxyinosine, or adenosine was prevented by small amounts of thiamine or by relatively high concentrations of either cytidine or uridine. Cytidine also reversed the inhibition by some purine and purine ribonucleoside analogues. Orotate phosphoribosyltransferase (OMP: pyrophosphate phosphoribosyltransferase, EC 2.4.2.10), a possible site of action for these compounds, was not inhibited directly by the toxic agents.
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There is considerable interest in defining the mechanisms of activation and sites of action of the large number of purine and purine nucleoside analogues which act as antimetabolites. A productive method used to study the intracellular activation of such analogues requires the isolation of bacterial and mammalian cell mutants resistant to the agents (3, 9) . These mutants can be checked for cross-resistance to other analogues and for loss of activating enzymes. Information regarding the sites of action of the analogues can be obtained by reversal studies and by contrasting their effects on various organisms (2, 20) .
In a previous report from this laboratory, we evaluated the antimicrobial activity of 2-fluoroadenine and 2-fluoroadenosine and performed cross-resistance studies with these compounds on several Escherichia coli mutants (33) . We have now extended these studies to include many other purines, purine nucleosides, and analogues, and have evaluated three parent E. coli lines and four derived mutants for the presence of various purine phosphoribosyltransferases and for cross-resistance to a number of active compounds.
MATERIALS AND METHODS
Guanine-8-"C, adenine-8-"C, and hypoxanthine- E. coli B Hill, E. coli ATCC 9637, E. coli ATCC 9637 resistant to 6 mM 6-thioguanine (E. coli ATCC 9637/6TG), E. coli ATCC 9637 resistant to 1 mM 2-fluoroadenosine (E. coli ATCC 9637/FAS), E. coli ATCC 9637 resistant to 2.5 mM 2,6-diaminopurine (E. coli ATCC 9637/DAP), E. coli B ATCC 11303, and E. coli B ATCC 11303 resistant to 5 mM 6-mercaptopurine (E. coli B ATCC 11303/6MP) were maintained on slants containing 1.5% agar, 0.1% NH4Cl, 0.73% K2HPO4, 0.3% KH2PO4, 0.012% MgSO4, and 8 ml of 50% glucose (autoclaved and added aseptically). Those organisms resistant to certain agents were maintained on the same slants to which the specified amount of compound had been added. For experimental studies, bacteria were grown in the liquid medium developed by Gray and Tatum (16) . This medium contained glucose, L-asparagine, and inorganic salts. The glucose was autoclaved separately and added prior to inoculation. For adaptation to broth cultures, a loop of bacteria growing on a slant was transferred to a tube of liquid medium and allowed to grow at 37 C overnight to an absorbance of 0.2 at 660 nm.
The analogues and reversing agents were sterilized by filtration through membrane filters (Millipore Corp.) and were added to 5.0 ml of sterile medium so that the volume was 6.0 ml. The tubes were inoculated with 20 jliters of a stock culture and were incubated at 37 C for 10 A compound was considered a reversing agent if it restored growth to more than 90% of control.
Assays for purine phosphoribosyltransferase activities were similar to those performed previously (18, 33) . Acetone powders of the E. coli lines were prepared and extracted for 20 min with stirring in 20 mM tris(hydroxymethyl)aminomethane (Tris)-chloride, pH 7.5. The assay system for all bases except 6-thioguanine contained 62 nmol of "4C-purine base, 500 nmol of magnesium 5-phosphoribosyl-1-pyrophosphate, 20 Mmol of Tris-chloride buffer (pH 7.5), 50 Mg of enzyme protein, and water, in a total of 250 Mliters.
Tubes without 5-phosphoribosyl-1-pyrophosphate served as controls, and no detectable product was formed in these. The reaction was allowed to proceed at 37 C for 30 min and was stopped by streaking a 50-Mliter portion onto paper strips. After the samples had dried, the strips were subjected to chromatography with a solvent of n-butyl alcohol and propionic acid (5, 18) . The developed chromatograms were scanned with a Packard 7201 radiochromatogram scanner to determine the extent of conversion of purine base to nucleotide. A spectrophotometric assay (18) was used to follow the conversion of 6-thioguanine to the nucleotide. The assay system contained 10 nmol of 6-thioguanine, 60 Mmol of Tris-chloride (pH 7.5), 5 Amol of MgCl2, 250 nmol of 5-phosphoribosyl-1-pyrophosphate, and 100 Mg of enzyme, in a total of 1 ml. The increase in absorbance at 255 nm was measured. The difference in extinction coefficients for the base and the nucleotide at this wavelength and this pH was 5,100. Adenosine deaminase was assayed spectrophotometrically by the method of Koch and Vallee (26) .
Orotate phosphoribosyltransferase was partially purified from a preparation of E. coli B Hill obtained by breaking the cells with a sonic cell disruptor. The preparation was heated for 3 min at 70 C, and the precipitated material was removed by centrifugation. The supernatant fluid was adjusted to pH 4.0 with glacial acetic acid, and the precipitate was collected and dissolved in 20 mM Tris-chloride buffer, pH 8.0. The preparation was applied to a small hydroxylapatite column, and elution was accomplished with a gradient of 1 to 200 mM potassium phosphate buffer, pH 8.0. The fractions with the highest activity were retained and pooled. The resulting preparation had a specific activity 64-fold greater than the crude extract. The assay for this enzyme was based on that of Flaks (13) and contained 300 nmol of sodium orotate, 100 nmol of 5-phosphoribosyl-1-pyrophosphate, 2 Mmol of MgCl2, 40 Mmol of Tris-chloride (pH 8.0), and enzyme, in a total volume of 1 ml. The initial rate of decrease of absorbance at 295 nm was measured.
RESULTS
Forty-five of 142 purines, purine nucleosides, and analogues tested against E. coli B Hill were inhibitory; of these, 27 were evaluated with the other six lines ( Table 1 ). The most inhibitory compounds to E. coli B Hill were the adenine and adenosine analogues with a 2-fluoro substituent. For 2-fluoroadenine, 2-fluoroadenosine, and 2-fluoro-5'-deoxyadenosine, concentrations less than 1 ,uM inhibited growth by 50%. Other strongly inhibitory compounds were adenosine, 6-thioguanosine, 6-thioguanine, 6-mercaptopurine, 6-mercaptopurine ribonucleoside, 2-azaadenine, 2'-deoxyinosine, 6-Naminoadenine, and inosine. Hypoxanthine was inhibitory to E. coli B Hill but not to any of the other lines. Only E. coli B Hill was sensitive to adenine, and only this line and ATCC 9637/ DAP were sensitive to 6-N-allyladenosine.
Except for hypoxanthine, there was little difference in sensitivity between E. coli B Hill and the other parent lines, E. coli ATCC 9637 were 10-fold less sensitive to 6-thioguanine and 6-thioguanosine than E. coli B Hill. All of the lines were inhibited by psicofuranine. For E. coli B Hill, concentrations of thiamine as low as 0.5 nM completely reversed the inhibition by adenosine, inosine, hypoxanthine, and 2'-deoxyinosine but not that by the analogues 2-fluoroadenine, 2-fluoroadenosine, 6-methylpurine, and 6-mercaptopurine. Neither pyridoxal, nicotinic acid, folic acid, nor pantothenic acid at a concentration of 50 nM reversed the inhibition by adenosine, but 50 nM riboflavine gave partial reversal. Guanine reversed the inhibition produced by several guanine analogues and a few other compounds but potentiated the inhibition of adenine and some other analogues ( Table 2) . Cytidine reversed the inhibition produced by 12 compounds, all of which were derivatives of either adenine or hypoxanthine. In other experiments, the inhibition by adenosine, inosine, hypoxanthine, or 2'-deoxyinosine was completely abolished by either cytidine or uridine and was partially prevented by either 2'-deoxyuridine or thymidine. Neither carbamylaspartate, orotate, cytosine, uracil, nor thymine had any effect.
A possible site of action for those agents reversed by cytidine was orotate phosphoribosyltransferase (OMP: pyrophosphate phosphoribosyltransferase, EC 2.4.2.10). This enzyme, in a 64-fold purified preparation, was examined. The pH optimum in Tris-chloride buffer was pH 8.0 to 9.0. The enzyme activity was proportional to the amount of protein added to the assay. The Michaelis constant for orotate was 24 uM, and that for 5-phosphoribosyl-1-pyrophosphate was 67 MM. Neither of these values changed when the concentration of the other substrate was varied. In assays for inhibition of this enzyme by 100 gM concentrations of purines, purine ribonucleosides, and analogues, none of 25, including those reversed by cytidine in growth studies, inhibited by more than 15%.
Measurement of the purine phosphoribosyltransferase activities of the parent and mutant cell lines showed that some of them had enzyme deficiencies ( Table 3 ). The ATCC 9637/FAS and ATCC 9637/DAP lines had no detectable adenine phosphoribosyltransferase activity, and the ATCC 9637/6TG line lacked xanthine and 6-thioguanine phosphoribosyltransferase activity. Guanine phosphoribosyltransferase activity was low for ATCC 9637/6TG and was moderately reduced for ATCC 9637/FAS, ATCC 9637/ DAP, and ATCC 11303. Hypoxanthine phosphoribosyltransferase activity was low in ATCC None of the resistant lines contained higher adenosine deaminase activity than the respective parent line. 30:1253, 1971 ), and there is no evidence from this study that it is present. The ribonucleosides of 6-Naminoadenine, purine, 2, 6-diaminopurine, 2-azaadenine, 6-N-methyladenine, 6-methylthiopurine, and b-methylpurine, all of which are known to be substrates for adenosine kinase (35; D. L. Hill, unpublished data), are less toxic to E. coli B Hill than their corresponding bases. The bases can be directly activated by adenine phosphoribosyltransferase, but ribonucleosides of adenine analogues apparently must first be cleaved to the respective bases before they are converted to nucleotides (21) . The 100-fold difference in toxicity between 2-azaadenine and 2-azaadenosine implies that the ribonucleoside is not a good substrate for the enzyme accomplishing the cleavage. 2-Azaadenosine is a good substrate for adenosine deaminase (P. W. Allan, personal communication), which could account for its low activity. The deamination product, 2-azainosine, is not available for testing, but 2-azahypoxanthine is not very inhibitory ( Table 2) .
The nucleosides which are more inhibitory than their bases to E. coli B Hill are adenosine, 6-N-hydroxyadenosine, 2-chloroadenosine, 2-fluoroadenosine, 2'-deoxyinosine, and 6-thioguanosine. The potent inhibition of growth of E. coli by adenosine has been previously reported (14, 19) . Only lines which have lost adenine phosphoribosyltransferase are resistant to 2-fluoroadenosine, an indication that this ribonucleoside must first be cleaved to the base before the ribonucleotide is produced. However, the line resistant to 2-fluoroadenosine apparently has, in addition to loss of adenine phosphoribosyltransferase, a mechanism for resistance to many ribonucleosides, for all those in Table 1 , except psicofuranine and those containing sulfur, are not inhibitory to this line. 2-Fluoro-5'-deoxyadenosine, which is as toxic as 2-fluoroadenine, is not very inhibitory to those lines which are resistant to 2-fluoroadenine and 2-fluoroadenosine. This analogue cannot be phosphorylated on the 5'-position and is apparently cleaved to the base before being converted to the nucleotide.
There is a difference between the inhibitory properties of 2, 6-diaminopurine and 8-aza-2, 6-diaminopurine. Those lines which have lost adenine phosphoribosyltransferase are markedly resistant to 2, 6-diaminopurine but are sensitive to 8-aza-2, 6-diaminopurine. ATCC 11303/6MP is more resistant to 8-aza-2, 6-diaminopurine than to 2,6-diaminopurine and is more resistant to 8-aza-2,6-diaminopurine than the parent line. This implies that 8-aza-2,6-diaminopurine is not a substrate for adenine phosphoribosyltransferase but is a substrate for the enzyme converting 6-mercaptopurine to the ribonucleotide. A further indication that 8-aza-2, 6-diaminopurine is not an adenine analogue is that its inhibition is reversed by guanine, which does not reverse the inhibition of 2,6-diaminopurine and actually potentiates the inhibition of 2, 6-diaminopurine ribonucleoside. VOL. 4, 1973 Psicofuranine, which inhibits guanosine monophosphate (GMP) synthetase (xanthosine 5'-phosphate: ammonia ligase [AMP], EC 6.3.4.1) without metabolic conversion (36) , is inhibitory to all of the cell lines studied. The toxicity of 6-N-allyladenosine to E. coli B Hill can also be accounted for by inhibition of GMP synthetase (19) . The (30) . In Schizosaccharomyces pombe, a single enzyme uses hypoxanthine, xanthine, or guanine (12). However, studies on the phosphoribosyltransferase activities of E. coli and Salmonella typhimurium have shown that one enzyme uses guanine, xanthine, and, to a lesser extent, hypoxanthine as substrates (10, 15, 23, 29, 31) . Another enzyme uses hypoxanthine most efficiently but also has some activity with guanine and 6-mercaptopurine (29) . Adenine phosphoribosyltransferase is clearly separate from the other enzymes (31 ity to 6-mercaptopurine and its ribonucleoside.
It is likely that, in addition to loss of a phosphoribosyltransferase, ATCC 11303/6MP has another mechanism of resistance to account for its broader spectrum of insensitivity. The additional mechanism could be desulfuration of thiopurines, a process reported for one mutant strain of E. coli (11) .
Since the pyrimidine ring of thiamine is derived metabolically from the ribonucleotide of 5-aminoimidazole (32) feedback inhibition or a lack of transport of purine ribonucleosides into the cells could account for the lack of inhibition. Although hypoxanthine is a common degradation product for the three nucleosides, it is less inhibitory than adenosine, and some lines are completely resistant to this base and to adenine but are sensitive to the nucleosides. A shift of the portion of purine phosphoribosyltransferases which are located in the pericytoplasmic space and which function in purine transport (21) to the cytoplasm would result in a deficient transport system for these bases. For sensitive lines, the toxic nucleosides apparently enter the cell, at least to some extent, without prior degradation to purine bases.
The reversal by cytidine of inhibition caused by some of the analogues could have been due to a direct effect of the agents on orotate phosphoribosyltransferase, but this possibility is eliminated by tests with the partially purified enzyme. It remains possible that some of the analogues, after conversion to the base if necessary, remove sufficient 5-phosphoribosyl-1-pyrophosphate from the intracellular pool to result in an indirect inhibition of the enzyme. In on October 19, 2017 by guest http://aac.asm.org/ Downloaded from cultured human cells, orotate inhibits the initial step in purine synthesis by depleting the cellular supply of this substrate (24) . The inhibition of growth of E. coli by N6-(A2-isopentenyl)adenosine is overcome by cytidine, uridine, deoxyuridine, or thymidine (7).
